Vice Provost and Dean of Research
Showing 341-360 of 2,499 Results
-
Ying-Li Chen
Assistant Director, Business Development and Strategic Marketing, Office of Technology Licensing (OTL)
BioYing-Li Chen is an Assistant Director, Business Development and Strategic Marketing and manages a team ranging from associates to interns at the Stanford Office of Technology Licensing (OTL). She joined OTL in 2019 and established the Business Development and Marketing Team to lead the technology marketing and public relations efforts. She connects industry partners with inventors to commercialize Stanford’s research and innovation through licensing, strategic alliances, and industry sponsored research. She has more than 11 years of experience in technology commercialization and entrepreneurship at Stanford University, University of California, San Francisco, and Johns Hopkins University.
-
Alan G. Cheng, MD
Edward C. and Amy H. Sewall Professor in the School of Medicine, Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsActive Wnt signaling maintains somatic stem cells in many organ systems. Using Wnt target genes as markers, we have characterized distinct cell populations with stem cell behavior in the inner ear, an organ thought to be terminally differentiated. Ongoing work focuses on delineating the developing significance of these putative stem/progenitor cells and their behavior after damage.
-
Edward C. Cheng
Affiliate, FSI
BioDr. Edward C. Cheng is a technology strategist and visionary leader. He serves as Senior Advisor for the cross-industry Safe AI Agents Consortium Group, whose members include Anthropic, Cohere, Meta, Microsoft, Oracle, PayPal, DoorDash, PwC, Inquiryon, and others. He is also the Chief Technology Officer and Executive Chairman of Inquiryon. Previously, Edward served as VP of AI at Oracle NetSuite and held senior leadership roles at HP.
Edward is the lead inventor of the Log-Structured Merge Tree (LSM Tree), a foundational data structure that enables low-latency, high-throughput, and high-velocity data processing. It is widely adopted by major data management systems across industry, including Google, Meta, X, Microsoft, Oracle, Hadoop, Cassandra, MongoDB, RocksDB, and many others.
His work on Safe AI Agents focuses on governance frameworks, human-centric AI principles, and multi-agent systems that align autonomous AI with democratic values and human oversight. He collaborates across academia, industry, and civil society to advance research, publish scholarly work, and help shape emerging best practices for safe and trustworthy AI agent development and deployment. He also speaks globally about the impacts and risks of AI agents and AGI with diverse communities.
Edward writes under the pen name Edward Sizhe on topics spanning faith, technology, and life purpose. His books include "AI and God," "Journey of Life or Death," and "Five Questions Toward Enriching the Meaning and Purpose of Life, available on Kindle and Amazon."
His research interests include AI agents, distributed big data systems, machine learning and deep learning, parallel search algorithms, high-performance computing, and distributed systems. He is also interested in biblical studies and archaeological evidence surrounding biblical events. Edward has published numerous scientific papers and holds multiple patents in AI, machine learning, and database systems. He previously worked with the Stanford Database Research Group and now serves as Senior Advisor and researcher at the Stanford Deliberative Democracy Lab.
Edward received his PhD in Computer Science from the University of London, his master’s degree from UC Berkeley, and an MBA from Columbia University. -
Paul Cheng MD PhD
Assistant Professor of Medicine (Cardiovascular Medicine)
BioDr. Cheng is a Cardiologist at Stanford University School of Medicine in the Department of Medicine and a member of the Cardiovascular Research Institute. Dr. Cheng received his BEng in Chemical Engineering and BSc in biology at MIT. He subsequently completed his MD/PhD at UCSF working in the Srivastava lab studying how extracellular morphogenic signals affect cardiac development and fate determination of cardiac progenitors. Dr. Cheng completed internal medicine residency and cardiology fellowship at Stanford, including a post-doctoral training in the Quertermous lab. His current clinical focus is in amyloidosis and cardio-oncology.
Dr. Cheng pioneered the application of single cell transcriptomic and epigenetic techniques to study human vascular diseases including atherosclerosis and aneurysm, and applied these techniques to investigate molecular mechanisms behind genetic risk factors for several human vascular diseases including atherosclerosis, and aortopathies such as Marfan's and Loey-Dietz syndrome. The Cheng lab takes a patient-to-bench-to-bedside approach to science. The lab focuses on elucidating new pathogenic mechanisms of human vascular diseases through combing human genetics and primary vascular disease tissues, with high-resolution transcriptomic and epigenetic profiling to generate novel hypothesis that are then tested in a variety of in vitro and in vivo models. The lab is focused on two broad questions: (1) understanding the biological underpinning of the differences in diseases propensities of different arterial segments in an individual (i.e. why do you have atherosclerosis and aneurysms in certain segments but not others), and (2) understanding the role of perivascular fibroblast in human vascular diseases.
Find out more about what the Cheng lab is up to, check out https://chenglab.stanford.edu -
Mike Cherry
Professor (Research) of Genetics, Emeritus
Current Research and Scholarly InterestsMy research involves identifying, validating and integrating scientific facts into encyclopedic databases essential for research and scientific education. Published results of scientific experimentation are a foundation of our understanding of the natural world and provide motivation for new experiments. The combination of in-depth understanding reported in the literature with computational analyses is an essential ingredient of modern biological research.
-
Glenn M. Chertow
Norman S. Coplon/Satellite Healthcare Professor of Medicine and Professor, by courtesy, of Epidemiology and Population Health and of Health Policy
Current Research and Scholarly Interestsclinical epidemiology, health services research, decision sciences, clinical trials in acute and chronic kidney disease
-
Emilie Cheung, MD
Associate Professor of Orthopaedic Surgery
Current Research and Scholarly InterestsPyrocarbon humeral head replacement
Clinical outcome after shoulder replacement
Clinical outcome after elbow replacement
Clinical outcomes following complex reconstruction of the shoulder and elbow,
Bone mineral density in the shoulder,
3D kinematics of the shoulder girdle after arthroplasty -
E.J. Chichilnisky
John R. Adler Professor, Professor of Neurosurgery and of Ophthalmology and, by courtesy, of Electrical Engineering
Current Research and Scholarly InterestsFunctional circuitry of the retina and design of retinal prostheses
-
Allis Chien
Affiliate, Mass Spectrometry Center
Current Role at StanfordEmeritus Staff:
Director, Stanford University Mass Spectrometry (SUMS) core resource laboratory
Staff Director, Stanford School of Medicine Service Centers -
Yueh-hsiu Chien
Professor of Microbiology & Immunology
Current Research and Scholarly InterestsContribution of T cells to immunocompetence and autoimmunity; how the immune system clears infection, avoids autoimmunity and how infection impacts on the development of immune responses.
-
Gheorghe Chistol
Assistant Professor of Chemical and Systems Biology
Current Research and Scholarly InterestsResearch in my laboratory is aimed at understanding how eukaryotes replicate their DNA despite numerous challenges (collectively known as replication stress), and more generally – how eukaryotic cells safeguard genome integrity. Specifically, we are investigating: (i) mechanisms that regulate the activity of the replicative helicase during replication stress, (ii) mechanisms that control the inheritance of epigenetic information during replication, and (iii) mechanisms of ubiquitin-mediated regulation of genome maintenance. We utilize single-molecule microscopy to directly image fluorescently-labeled replication factors and track them in real time in Xenopus egg extracts. I developed this system as a postdoctoral fellow, and used it to monitor how the eukaryotic replicative helicase copes with DNA damage. We plan to further extend the capabilities of this platform to directly visualize other essential replication factors, nucleosomes, and regulatory post-translational modifications like ubiquitin chains. By elucidating molecular mechanisms responsible for maintaining genome stability, we aim to better understand the link between genome instability and cancer, and how these mechanisms can be harnessed to improve disease treatment.
-
Bill Chiu
Associate Professor of Surgery (Pediatric Surgery)
BioDr. Chiu obtained his B.S. degree in Biological Sciences and graduated with Honors from Stanford University. After graduating, he received his Medical Degree at Northwestern University Feinberg School of Medicine, where he remained for his internship and General Surgery residency training. Dr. Chiu completed his Pediatric Surgery training at The Children’s Hospital of Philadelphia. He is an Associate Professor at Stanford University School of Medicine where he has an active research program studying innovative approaches to treat patients with neuroblastoma.
